CoChat

Identification through high‐throughput screening of 4'‐methoxyflavone and 3',4'‐dimethoxyflavone as novel neuroprotective inhibitors of parthanatos

Open access
Fatokun, A A, Liu, J O, Dawson, V L, Dawson, T M · 2013 · British Journal of Pharmacology
Cited by 45

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background and Purpose: The current lack of disease‐modifying therapeutics to manage neurological and neurodegenerative conditions justifies the development of more efficacious agents. One distinct pathway leading to neuronal death in these conditions and which represents a very promising and attractive therapeutic target is parthanatos, involving overactivation of PARP‐1. We therefore sought to identify small molecules that could be neuroprotective by targeting the pathway. Experimental Approach: Using H e L a cells, we developed and optimized an assay for high‐throughput screening of about 5120 small molecules. Structure–activity relationship (SAR) study was carried out in H e L a and SH‐SY5Y cells for molecules related to the initial active compound. The neuroprotective ability of each active compound was tested in cortical neuronal cultures. Key Results: 4'‐Methoxyflavone (4MF) showed activity by preventing the decrease in cell viability of H e L a and SH‐SY5Y cells caused by the DNA‐alkylating agent,N‐methyl‐N‘‐nitro‐N‐nitrosoguanidine (MNNG), which induces parthanatos. A similar compound from the SAR study, 3',4'‐dimethoxyflavone (DMF), also showed significant activity. Both compounds reduced the synthesis and accumulation of poly (ADP‐ribose) polymer and protected cortical neurones against cell death induced by NMDA. Conclusions and Implications: Our data reveal additional neuroprotective members of the flavone class of flavonoids and show that methoxylation of the parent flavone structure at position 4′ confers parthanatos‐inhibiting activity while additional methoxylation at position 3′, reported by others to improve metabolic stability, does not destroy the activity. These molecules may therefore serve as leads for the development of novel neurotherapeutics for the management of neurological and neurodegenerative conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12201

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 45

Metadata

Authors
Fatokun, A. A., Liu, J. O., Dawson, V. L., & Dawson, T. M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2013-06-21
Volume
169
Issue
6
Pages
1263-1278
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1501041661
Cited by
45
References
4
FWCI
2.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.